NIDA-CTO-0004
Division
HEAL Study
Investigator(s)
Title
Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline
Short Description
This is a human laboratory clinical pharmacology study to assess potential interactions between intravenous methamphetamine challenge and treatment with oral selegiline.
Release Date
Aug 01, 2016
Description
The primary objective of this study is to determine the safety of the selegiline concurrent with dmethamphetamine challenges of 15 mg and 30 mg i.v. The primary outcome measures are cardiovascular responses (HR, BP) to the i.v. methamphetamine challenges.
Accessibility Notice
Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.